Comparison of Patients Treated with Natalizumab and Interferon-beta/Glatiramer Using Propensity-Matched Multiple Sclerosis Registry Data

Timothy Spelman, Fabio Pellegrini, Annie Zhang, Robert Hyde, Amy Pace, Shibeshih Belachew, Maria Trojano, Heinz Wiendl, Ludwig Kappos, Freek Verheul, Francois Grand-Maison, Guillermo Izquierdo, Helmut Butzkueven